The first half of 2025 has seen an acceleration of M&A activity, including large-scale life sciences transactions, such as Merck’s $3.9 billion acquisition of SpringWorks, Sanofi’s $9.5 billion acquisition of Blueprint...more
8/14/2025
/ Acquisitions ,
Antitrust Litigation ,
Antitrust Provisions ,
Enforcement Actions ,
EU ,
European Commission ,
Hatch-Waxman ,
Johnson & Johnson ,
Life Sciences ,
Merger Controls ,
Mergers ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Regulatory Authority ,
Sanofi ,
Settlement Agreements ,
UK ,
UK Competition and Markets Authority (CMA)
The first quarter of 2025 brought a surge of high-profile merger activity in the technology and artificial intelligence (AI) space, offering an early test of how antitrust regulators under the new Trump administration will...more
6/17/2025
/ Acquisitions ,
Antitrust Litigation ,
Antitrust Provisions ,
Apple ,
Artificial Intelligence ,
Department of Justice (DOJ) ,
European Commission ,
Federal Trade Commission (FTC) ,
Google ,
Hewlett-Packard ,
IBM ,
Mergers ,
Popular ,
Technology Sector ,
Trump Administration ,
UK Competition and Markets Authority (CMA)